A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose in Subjects with Port-wine Birthmarks Treated with Hemoporfin Photodynamic Therapy
Latest Information Update: 01 Oct 2024
At a glance
- Drugs Hematoporphyrin monomethyl ether (Primary)
- Indications Port-wine stain
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Most Recent Events
- 01 Aug 2024 Planned initiation date changed from 30 Dec 2022 to 30 Aug 2024.
- 01 Aug 2024 Status changed from not yet recruiting to recruiting.
- 07 Sep 2023 Planned End Date changed from 1 Sep 2024 to 1 Apr 2026.